ArticleBMC microbiology2024

Saliva‑microbiome‑derived signatures: expected to become a potential biomarker for pulmonary nodules (MCEPN-1).

Yifeng Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.